Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 292281 - 292300 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01FX17) sacituzumab govitecan | TRODELVY® PD.C.S.INF 200MG/VIAL BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GILEADSCIENCESIRELANDUC,CO.CORK,IRELAND |
| Greece | (L01FX20) tremelimumab | IMJUDO C/S.SOL.IN 20MG/ML BT X 1 VIAL X 1,25ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FX20) tremelimumab | IMJUDO C/S.SOL.IN 20MG/ML BT X 1 VIAL X 15ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FX22) loncastuximab tesirine | ZYNLONTA PD.C.S.INF 10MG/VIAL BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell | SWEDISHORPHANBIOVITRUMAB(PUBL),STOCKHOLM,SWEDEN |
| Greece | (L01FX24) teclistamab | TECVAYLI INJ.SOL 10MG/ML VIAL BT X 1 VIAL X 3 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FX24) teclistamab | TECVAYLI INJ.SOL 90MG/ML VIAL BT X 1 VIAL X 1.7 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FX25) mosunetuzumab | LUNSUMIO C/S.SOL.IN 1MG/1ML BT X 1 VIAL X 1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FX25) mosunetuzumab | LUNSUMIO C/S.SOL.IN 30MG/30ML BT X 1 VIAL X 30 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FX26) mirvetuximab soravtansine | ELAHERE C/S.SOL.IN 5MG/ML 1 VIAL (GLASS) X 20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
| Greece | (L01FX27) epcoritamab | TEPKINLY CS.INJ.SOL 4mg/0,8ml vial (5mg/ml) BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
| Greece | (L01FX27) epcoritamab | TEPKINLY INJ.SOL 48mg/0,8ml vial (60mg/ml) BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
| Greece | (L01FX28) glofitamab | COLUMVI C/S.SOL.IN 10MG/VIAL BT X 1 VIAL X 10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FX28) glofitamab | COLUMVI C/S.SOL.IN 2,5MG/VIAL BT X 1 VIAL X 2.5 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FX29) talquetamab | TALVEY INJ.SOL 2MG/ML BT X 1 VIAL X 1.5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FX29) talquetamab | TALVEY INJ.SOL 40MG/ML BT X 1 VIAL X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FX32) elranatamab | ELREXFIO INJ.SOL 40MG/ML BT X 1 VIAL X 44MG (1.1ML) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FX32) elranatamab | ELREXFIO INJ.SOL 40MG/ML BT X 1 VIAL X 76MG (1.9ML) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FY01) pertuzumab and trastuzumab | PHESGO INJ.SOL (1200+600)MG/VIAL 1 VIAL x 15 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FY01) pertuzumab and trastuzumab | PHESGO INJ.SOL (600+600)MG/VIAL 1 VIAL x 10 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FY02) nivolumab and relatlimab | OPDUALAG C/S.SOL.IN (240+80)MG/VIAL BT X 1 VIAL X 20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
Pages
